Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carcinoma, Lobular"" wg kryterium: Temat


Tytuł:
Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease.
Autorzy:
Saad HA; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt. ebramos_.
Baz A; Surgical Department, Alahrar Teaching Hospital, Zagazig University, Zagazig City, 55971, Egypt.
Riad M; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Eraky ME; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
El-Taher A; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Farid MI; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Sharaf K; Surgical Department, Faculty of Medicine, Zagazig University, Zagazig City, 44661, Egypt.
Said HEM; Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig City, 55971, Egypt.
Ibrahim LA; Surgical Department, AlAzhar University, Nasr City, Cairo, 55888, Egypt.
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2024 Jan 25; Vol. 25 (1), pp. 9. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Breast Neoplasms*/surgery
Carcinoma, Ductal, Breast*/pathology
Carcinoma, Ductal, Breast*/secondary
Carcinoma, Ductal, Breast*/surgery
Carcinoma, Lobular*/pathology
Carcinoma, Lobular*/secondary
Carcinoma, Lobular*/surgery
Humans ; Female ; Mastectomy ; Vimentin/therapeutic use ; Tumor Microenvironment ; Matrix Metalloproteinase 1/therapeutic use
Czasopismo naukowe
Tytuł:
Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database.
Autorzy:
Balatico M; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Ruano AL; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Cleary AS; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Lomo L; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Gulbahce HE; Department of Pathology and Laboratory Medicine, Huntsman Cancer Institute, University of Utah Health, Salt Lake City.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Mar 01; Vol. 148 (3), pp. 263-264.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Male ; Humans
Czasopismo naukowe
Tytuł:
Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients.
Autorzy:
Agaoglu NB; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.
Unal B; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Hayes CP; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Walker M; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ng OH; Department of Medical Biology, School of Medicine, Acibadem University, Istanbul, Turkey.
Doganay L; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.
Can ND; Department of Molecular Biology Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Ghazani AA; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6852. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/epidemiology
Breast Neoplasms*/genetics
Carcinoma, Lobular*
Carcinoma, Ductal, Breast*
Humans ; Female ; Genomics ; Oncogenes
Czasopismo naukowe
Tytuł:
Significance of tumor-infiltrating lymphocytes in tumor regression in breast cancer: A study in a tertiary care cancer center in South India.
Autorzy:
Mishra B; Department of Lab Medicine, Basavatarakam Indo American Cancer Hospital, Hyderabad, India.
Kodandapani S; Department of Lab Medicine, Basavatarakam Indo American Cancer Hospital, Hyderabad, India.
Challa S; Department of Lab Medicine, Basavatarakam Indo American Cancer Hospital, Hyderabad, India.
Dash S; Department of Oncopathology, Acharya Harihar Post-Graduate Institute of Cancer, Cuttack, Odisha, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Oct 01; Vol. 19 (7), pp. 1837-1843. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/therapy
Carcinoma, Lobular*
Female ; Humans ; Lymphocytes, Tumor-Infiltrating ; Tertiary Healthcare ; India/epidemiology
Czasopismo naukowe
Tytuł:
Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer.
Autorzy:
Cosar R; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Sut N; Department of Biostatistics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Topaloglu S; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Tastekin E; Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Nurlu D; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Ozler T; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Şenödeyici E; Faculty of Medicine, Trakya University, Edirne, Turkey.
Dedeli M; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Chousein M; Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jul 10; Vol. 18 (7), pp. e0283445. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Lobular*/therapy
Carcinoma, Lobular*/pathology
Breast Neoplasms, Male*/surgery
Carcinoma, Ductal*
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Male ; Mastectomy ; Treatment Outcome ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Autorzy:
Wang Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Liang Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Ye F; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Luo D; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Jin Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Li Y; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Zhao W; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Chen B; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Wang L; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Yang Q; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.; Research Institute of Breast Cancer, Shandong University, Jinan, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 18597-18610. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Bone Neoplasms*
Humans ; Female ; Retrospective Studies ; Prognosis ; Receptor, ErbB-2/metabolism
Czasopismo naukowe
Tytuł:
Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Autorzy:
Wang S; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Li W; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Li S; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Liu X; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Zhang L; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Hao C; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Meng W; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Zhao W; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Tong Z; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Sep; Vol. 31 (6), pp. 1075-1084. Date of Electronic Publication: 2023 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Gastrointestinal Neoplasms*
Humans ; Female ; Retrospective Studies ; Prognosis ; Endoscopy, Gastrointestinal
Czasopismo naukowe
Tytuł:
Aquaglyceroporins in Human Breast Cancer.
Autorzy:
Kirkegaard T; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.; Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark.
Riishede A; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.
Tramm T; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.; Department of Pathology, Aarhus University Hospital, 8200 Aarhus N, Denmark.
Nejsum LN; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Aug 31; Vol. 12 (17). Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*
Aquaglyceroporins*
Carcinoma, Lobular*
Humans ; Female ; Biological Transport ; Cell Membrane
Czasopismo naukowe
Tytuł:
Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Autorzy:
Jani C; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Lotz M; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Keates S; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Gupta Y; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Walker A; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Al Omari O; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Parvez A; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Patel D; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Gnata M; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Perry J; Department of Pathology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Khorashadi L; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Weissmann L; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Pories SE; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2023 Apr 18; Vol. 2023, pp. 8185446. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Breast Carcinoma In Situ*/diagnostic imaging
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/surgery
Carcinoma in Situ*/diagnosis
Carcinoma in Situ*/pathology
Carcinoma in Situ*/surgery
Carcinoma, Intraductal, Noninfiltrating*/diagnostic imaging
Carcinoma, Intraductal, Noninfiltrating*/surgery
Carcinoma, Lobular*/diagnostic imaging
Carcinoma, Lobular*/surgery
Precancerous Conditions*/pathology
Female ; Humans ; Biopsy ; Biopsy, Large-Core Needle ; Hyperplasia ; Observational Studies as Topic
Czasopismo naukowe
Tytuł:
Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?
Autorzy:
Tabár L; Falun Central Hospital, Lasarettsvägen 10, 791 82 Falun, Sweden.
Bozó R; Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Korányi Street 6, H-6720 Szeged, Hungary.
Dean PB; Department of Diagnostic Radiology, Faculty of Medicine, University of Turku, FI-20014 Turun, Finland.
Ormándi K; Department of Radiology, University of Szeged, Semmelweis Street 6, H-6725 Szeged, Hungary.
Puchkova O; Department of Breast Imaging, Il'inskaya Hospital, Novorizhskoye Highway 9 km, 101000 Moscow, Russia.
Oláh-Németh O; Department of Pathology, University of Szeged, Állomás Street 2, H-6725 Szeged, Hungary.
Németh IB; Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Korányi Street 6, H-6720 Szeged, Hungary.
Veréb Z; Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Korányi Street 6, H-6720 Szeged, Hungary.
Yen MF; School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Wuxing Street, Taipei 110, Taiwan.
Chen LS; School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Wuxing Street, Taipei 110, Taiwan.
Chen HH; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Hsuchow Road, Taipei 100, Taiwan.
Vörös A; Department of Pathology, University of Szeged, Állomás Street 2, H-6725 Szeged, Hungary.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 28; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Lobular*/metabolism
Breast Neoplasms*/metabolism
Mammary Glands, Human*/metabolism
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Breast/metabolism ; Epithelial Cells/metabolism
Czasopismo naukowe
Tytuł:
TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors.
Autorzy:
Bou-Dargham MJ; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.
Sha L; Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.
Sarker DB; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.
Krakora-Compagno MZ; Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
Chen Z; Abbisko Therapeutics, Shanghai 200100, China.
Zhang J; Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.
Sang QA; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.; Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 27; Vol. 24 (11). Date of Electronic Publication: 2023 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/metabolism
Carcinoma, Lobular*/metabolism
Triple Negative Breast Neoplasms*/pathology
Carcinoma, Ductal*/metabolism
Humans ; Female ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Lymphocytes, Tumor-Infiltrating ; RNA-Seq
Czasopismo naukowe
Tytuł:
First diagnosed invasive lobular carcinoma of the breast combined with gastric metastasis and bone metastasis: a case report and review of the literature.
Autorzy:
Sun L; Department of Breast Surgery, Second Affiliated Hospital of Jilin University, Changchun, 130041, China.
Liu J; Department of Breast Surgery, Second Affiliated Hospital of Jilin University, Changchun, 130041, China.
Guo M; Department of Breast Surgery, Second Affiliated Hospital of Jilin University, Changchun, 130041, China.
Xu J; Department of Breast Surgery, Second Affiliated Hospital of Jilin University, Changchun, 130041, China.
Wang D; Department of Breast Surgery, Second Affiliated Hospital of Jilin University, Changchun, 130041, China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2023 Mar 25; Vol. 23 (1), pp. 133. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Carcinoma, Lobular*/therapy
Carcinoma, Lobular*/diagnosis
Carcinoma, Lobular*/pathology
Breast Neoplasms*/pathology
Female ; Humans ; Biopsy
Czasopismo naukowe
Tytuł:
Intraoperative Lymph Node Assessment (Touch Preparation Only) for Metastatic Breast Carcinoma in Neoadjuvant and Non-neoadjuvant Settings.
Autorzy:
Ersoy E; From the Department of Pathology (Ersoy, Elsayad, Pandiri, Cao, Crisi), University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield.; Ersoy is currently with the Department of Pathology of Memorial Sloan Kettering Cancer Center, New York, New York.
Elsayad M; From the Department of Pathology (Ersoy, Elsayad, Pandiri, Cao, Crisi), University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield.
Pandiri M; From the Department of Pathology (Ersoy, Elsayad, Pandiri, Cao, Crisi), University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield.
Knee A; From the Department of Medicine (Knee), University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield.
Cao QJ; From the Department of Pathology (Ersoy, Elsayad, Pandiri, Cao, Crisi), University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield.
Crisi GM; From the Department of Pathology (Ersoy, Elsayad, Pandiri, Cao, Crisi), University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield.; Ersoy is currently with the Department of Pathology of Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Feb 01; Vol. 147 (2), pp. 149-158.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Ductal, Breast*/pathology
Carcinoma, Lobular*/surgery
Carcinoma, Lobular*/pathology
Breast Neoplasms*/surgery
Breast Neoplasms*/drug therapy
Humans ; Female ; Retrospective Studies ; Neoadjuvant Therapy ; Touch ; Lymph Nodes/pathology ; Axilla/pathology ; Sentinel Lymph Node Biopsy/methods ; Lymph Node Excision
Czasopismo naukowe
Tytuł:
Molecularly Confirmed Female Donor-Transmitted Lobular Breast Cancer to Male following Renal Transplantation.
Autorzy:
Cooper JM; Medical School for International Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Samueli B; Medical School for International Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.; Department of Pathology, Soroka University Medical Center, Be'er Sheva, Israel.
Mazor E; Department of Urology, Soroka University Medical Center, Be'er Sheva, Israel.
Kian W; The Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Goldvaser H; The Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Ben-Arie G; Medical School for International Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.; Department of Radiology, Soroka University Medical Center, Be'er Sheva, Israel.
Pokaż więcej
Źródło:
Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2023; Vol. 90 (1), pp. 63-68. Date of Electronic Publication: 2022 May 02.
Typ publikacji:
Case Reports
MeSH Terms:
Kidney Transplantation*/adverse effects
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Carcinoma, Lobular*/diagnosis
Carcinoma, Lobular*/etiology
Humans ; Male ; Female ; Aged ; In Situ Hybridization, Fluorescence ; Tissue Donors ; Treatment Outcome
Raport
Tytuł:
Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.
Autorzy:
Akdeniz D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Kramer I; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
van Deurzen CHM; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands.
Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Schaapveld M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Westenend PJ; Department of Pathology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Voogd AC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.
Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Steyerberg EW; Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.
Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Schmidt MK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3123-3133. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/pathology
Carcinoma, Lobular*/pathology
Neoplasms, Second Primary*/epidemiology
Humans ; Female ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł:
Surgical Management of the Axilla in Invasive Lobular Carcinoma in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database.
Autorzy:
Sinner HF; Department of Breast Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Naffouje S; Department of Surgical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Selfridge JM; Department of Breast Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Lee MC; Department of Breast Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Hoover SJ; Department of Breast Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Laronga C; Department of Breast Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Oct 29; Vol. 29 (11), pp. 8197-8206. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Lobular*/surgery
Carcinoma, Lobular*/drug therapy
Carcinoma, Lobular*/pathology
Carcinoma, Ductal, Breast*/pathology
Breast Neoplasms*/pathology
Humans ; Female ; Axilla/pathology ; Sentinel Lymph Node Biopsy
Czasopismo naukowe
Tytuł:
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Autorzy:
Lee J; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Ku GY; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Lee H; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Park HS; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Ku JS; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Kim JY; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Park S; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Park BW; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1074-1080. Date of Electronic Publication: 2021 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*/diagnosis
Breast Carcinoma In Situ*/pathology
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*/diagnosis
Breast Neoplasms*/surgery
Calcinosis*/diagnosis
Calcinosis*/surgery
Carcinoma in Situ*/pathology
Carcinoma, Intraductal, Noninfiltrating*/diagnosis
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Intraductal, Noninfiltrating*/surgery
Carcinoma, Lobular*/diagnosis
Carcinoma, Lobular*/pathology
Carcinoma, Lobular*/surgery
Biopsy ; Female ; Humans ; Receptors, Progesterone
Czasopismo naukowe
Tytuł:
Invasive Lobular Carcinoma Mimicking Encapsulated Papillary Carcinoma with a Literature Review: A Rare Variant Detected Serendipitously.
Autorzy:
Zheng L; Department of Pathology and Laboratory Medicine, McGovern Medical School, 12340The University of Texas Health Science Center at Houston, Houston, TX, USA.
Saluja K; Department of Pathology and Laboratory Medicine, McGovern Medical School, 12340The University of Texas Health Science Center at Houston, Houston, TX, USA.
Guo T; Department of Pathology and Laboratory Medicine, McGovern Medical School, 12340The University of Texas Health Science Center at Houston, Houston, TX, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2022 Dec; Vol. 30 (8), pp. 912-920. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Lobular*/pathology
Carcinoma, Papillary*/diagnosis
Carcinoma, Papillary*/pathology
Breast Neoplasms*/pathology
Carcinoma in Situ*/pathology
Humans ; Female ; Cadherins ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Hypothalamus Presenting as a Primary Pituitary Lesion Presenting 17 Years Later-Report of a Case and Review of the Literature.
Autorzy:
Aisner SC; 12286Rutgers-New Jersey Medical School, Newark NJ.
Sharer L; 12286Rutgers-New Jersey Medical School, Newark NJ.
Liu JK; 12286Rutgers-New Jersey Medical School, Newark NJ.
Baisre de Leon A; 12286Rutgers-New Jersey Medical School, Newark NJ.
Heller DS; 12286Rutgers-New Jersey Medical School, Newark NJ.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2022 Oct; Vol. 30 (7), pp. 789-791. Date of Electronic Publication: 2022 Mar 02.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Breast/pathology ; Diagnosis, Differential ; Female ; Humans ; Hypothalamus/pathology
Czasopismo naukowe
Tytuł:
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Autorzy:
Fox SB; Department of Pathology, Peter MacCallum Cancer Centre, Level 4 Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia.
Webster F; International Collaboration on Cancer Reporting, Surry Hills, NSW, Australia.
Chen CJ; Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chua B; Prince of Wales Clinical School, UNSW Sydney, The University of New South Wales, Randwick, NSW, Australia.
Collins L; Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, and Harvard Medical School, Boston, MA, USA.
Foschini MP; Department Anatomic Pathology, University of Bologna, Department of Biomedical and Neuromotor Sciences Unit of Anatomic Pathology at Bellaria Hospital, Bologna, Italy.
Bruce Mann G; The Breast Service, The Royal Melbourne Hospital, Parkville, VIC, Australia.
Millar E; Department of Anatomical Pathology, NSW Heath Pathology St George Hospital, Kogarah NSW 2217 & St George & Sutherland Clinical School, Sydney, Australia.
Pinder SE; School of Cancer & Pharmaceutical Sciences, King's College London, 9th Floor, Innovation Hub, Comprehensive Cancer Centre at Guy's Hospital, London, UK.
Rakha E; Department of Histopathology, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Shaaban A; Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham and Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Tan BY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Tse G; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
Watson P; Department of Pathology, Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer Agency, Canada Victoria, British Columbia, Canada.
Tan PH; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 467-476. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*
Carcinoma in Situ*
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Papillary*
Female ; Humans ; Hyperplasia ; Pathologists
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies